<p>Validation of the Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio in Patients with Surgically Treated Non-Metastatic Renal Cell Carcinoma</p>-Reference-Cited by-同舟云学术

Validation of the Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio in Patients with Surgically Treated Non-Metastatic Renal Cell Carcinoma

Published:2020-08 Issue: Volume:Volume 13 Page:8287-8297
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Hu Xu^ORCID,Yang Zhi-Qiang,Dou Wei-Chao,Shao Yan-Xiang,Wang Yao-Hui,Lia Thongher,Li Xiang

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference31 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update

3. Long-term Risk of Recurrence in Surgically Treated Renal Cell Carcinoma: A Post Hoc Analysis of the Eastern Cooperative Oncology Group—American College of Radiology Imaging Network E2805 Trial Cohort

4. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

5. Cancer statistics, 2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preoperative Albumin-to-Alkaline Phosphatase Ratio as an Independent Predictor of Lymph Node Involvement in Penile Cancer;Medicina;2024-02-28

2. Prognostic value of preoperative albumin-to-alkaline phosphatase ratio in patients with surgically treated urological cancer: a systematic review and meta-analysis;Frontiers in Oncology;2023-11-09

3. Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Marker of Nivolumab Monotherapy for Previously Treated Metastatic Renal Cell Carcinoma;In Vivo;2021